Ingerid Nesthus
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Rheumatology top 5%
- Folate and B Vitamins Research
Papers in
- Hematology 14
- Multiple Myeloma Research and Treatments 7
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 3
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Neutropenia and Cancer Infections 3
- Co-authors
- Helga Refsum (1 shared paper)Per Magne Ueland (1 shared paper)A. B. Guttormsen (1 shared paper)Jørn Schneede (1 shared paper)Ottar Nygård (1 shared paper)Ingemar Turesson (5 shared papers)Øystein Bruserud (7 shared papers)Anders Waage (2 shared papers)
In The Last Decade
Ingerid Nesthus
27 papers receiving 853 citations
Peers
Comparison fields: 5 of 77
- Hematology 351
- Rheumatology 242
- Oncology 221
- Immunology 105
- Genetics 43
Countries citing papers authored by Ingerid Nesthus
This map shows the geographic impact of Ingerid Nesthus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingerid Nesthus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingerid Nesthus more than expected).
Fields of papers citing papers by Ingerid Nesthus
This network shows the impact of papers produced by Ingerid Nesthus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingerid Nesthus. The network helps show where Ingerid Nesthus may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingerid Nesthus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 223 | |
| 2 | 2015 | 127 | |
| 3 | 2001 | 73 | |
| 4 | Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. | 1995 | 59 |
| 5 | 2006 | 51 | |
| 6 | Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation. | 2006 | 51 |
| 7 | 2004 | 48 | |
| 8 | 2008 | 43 | |
| 9 | 2005 | 37 | |
| 10 | 2009 | 36 | |
| 11 | 1981 | 26 | |
| 12 | 2003 | 26 | |
| 13 | 1997 | 18 | |
| 14 | A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity | 2008 | 16 |
| 15 | 2003 | 11 | |
| 16 | 2011 | 9 | |
| 17 | 1997 | 6 | |
| 18 | 1985 | 4 | |
| 19 | Lung cancer. Symptoms, signs and diagnostic criteria. | 1979 | 4 |
| 20 | 1999 | 2 |
About Ingerid Nesthus
Ingerid Nesthus is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Emergency Medicine, having authored 28 papers that have together received 882 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Cancer Treatment and Pharmacology (3 papers), Neutropenia and Cancer Infections (3 papers), Hematological disorders and diagnostics (2 papers), Epilepsy research and treatment (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (351 citations), Rheumatology (242 citations), Oncology (221 citations), Immunology (105 citations) and Genetics (43 citations). Ingerid Nesthus has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Helga Refsum, Per Magne Ueland, A. B. Guttormsen, Jørn Schneede, Ottar Nygård, Ingemar Turesson, Øystein Bruserud, Anders Waage, Karin Fahl Wader and Hanne Hella. Their work appears in journals such as Cancer Immunology Immunotherapy, Transfusion, Leukemia Research, European Journal Of Haematology and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.